Profil
Sondra S.
Newman is currently the Global Head-Investor Relations at Repligen Corp.
Prior to this, she worked as the Director-Investor Relations at NitroMed, Inc.
Aktive Positionen von Sondra S. Newman
| Unternehmen | Position | Beginn |
|---|---|---|
| REPLIGEN CORPORATION | Investor Relations Contact | - |
Ehemalige bekannte Positionen von Sondra S. Newman
| Unternehmen | Position | Ende |
|---|---|---|
NitroMed, Inc.
 NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | Public Communications Contact | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| REPLIGEN CORPORATION | Health Technology |
| Private Unternehmen | 1 |
|---|---|
NitroMed, Inc.
NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | Health Technology |
